MedTrace Logo

Effects and Consequences for Mother and Child From Treatment for Depression

NCT02185547 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2020-01-18

No results posted yet for this study

Summary

This study targets women with moderate depression during pregnancy. We aim to investigate the direct effect of the newborn child and the long term consequences on the cognitive developement on children who´s mother has been treated with CBT alone or in combination with antidepressants.

Conditions

  • Pregnancy
  • Moderate Depression

Interventions

DRUG

Zoloft

Sertraline treatment 25 mg

BEHAVIORAL

ICBT

Internet behavioral cognitive therapy only

Sponsors & Collaborators

  • Katarina Wide

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-21
Primary Completion
2019-11-04
Completion
2019-11-04

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02185547 on ClinicalTrials.gov